Abstract
Background: Lung cancer remains the most common primary tumor responsible for brain metastases making up to 40% to 50% of cases. Brain metastases from NSCLC is associated with poor prognosis. Aim: The aim of this study is to analyze the risk factors and treatment outcome of patients with NSCLC who developed brain metastases; and to identify which subgroup of these patients is associated with better survival outcome. Methods: We analyzed all patients with NSCLC presented to Kasralainy Center of Clinical Oncology and Nuclear Medicine (NEMROCK) during the period between January 2006 and December 2012. Seven hundred and fourteen patients were found, from which 132 had clinical evidence of brain metastases. Results: The median time to development of brain metastases (TTBM) was 6 months. Factors associated with longer TTBM were good PS (1-2) (P=0.004), early stages at presentation (stage II good PS (1&2) at development of brain metastases (P<0.0001), controlled lung primary (P<0.0001), absence of extracranial metastases (P=0.019), the use of chemotherapy after development of brain metastases (P<0.0001) and whole brain irradiation (P=0.001). Controlled lung primary and administration of chemotherapy were independent prognostic factors associated with higher OS (P= 0.006 and 0.02 respectively). Conclusion: After development of brain metastases; patients with good PS(1-2), controlled lung primary and absence of extracranial metastases are associated with better outcome than other cases.
Highlights
Lung cancer remains the most common lethal malignancy worldwide
This retrospective study included all Non-Small Cell Lung Cancer (NSCLC) patients presented to Kasr Al-Ainy Center of Clinical Oncology and Nuclear Medicine (NEMROCK) during the period from January 2006 to December 2012
Of the 132 patients enrolled in this work, 65 patients (49.2%) had BM at initial presentation
Summary
Lung cancer remains the most common lethal malignancy worldwide. it is the leading cause of cancer mortality in both men and women, being responsible for 26-27% of all cancer mortality[1].Data collected for the year 2008, from the Middle East and Africa, revealed that about 16,600 lung cancer cases were newly diagnosed in the Arab countries. Lung cancer remains the most common lethal malignancy worldwide. Lung cancer remains the most common primary tumor responsible for brain-metastases (BM) leading to 40% -50% of cases. Factors associated with longer TTBM were better Eastern Cooperative Oncology Group (ECOG) performance status score 1 -2 (p = 0.004), early stages at presentation (stage I-II) (p < 0.0001), and administration of chemotherapy (p < 0.0001). Factors associated with longer OS were better performance status (ECOG 1- 2) at development of BM (p
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
